1. Kidney transplant outcomes in patients with antibodies to human neutrophil antigen 3a.
- Author
-
Cannon E, Stevenson K, Little AM, McKenzie D, Hastie C, Calvert A, Poles A, Battle R, McConnell S, Phelan PJ, and Turner D
- Subjects
- Pregnancy, Humans, Female, Male, Retrospective Studies, Neutrophils, Autoantibodies, Living Donors, HLA Antigens, Graft Rejection, Isoantibodies, Graft Survival, Kidney Transplantation adverse effects
- Abstract
Background: Antibody mediated rejection (ABMR) of kidney transplants has been shown to occur in the absence of a known donor specific antibody to human leucocyte antigen (HLA). Antibodies to the human neutrophil antigen (HNA) system have been detected in kidney transplant recipients and linked to ABMR in the absence of an HLA donor specific antibody (DSA), but there remains limited literature regarding this., Methods: Case series analysis was carried out examining three cases of HNA-3a antibody positive flow cytometry cross match (FC-XM) from two transplant centres in Scotland., Results: All patients included were female and had been sensitised as a result of pregnancy. One live donor recipient with HNA-3a antibodies identified prior to transplant received ATG induction and has had a good outcome. The remaining two patients received deceased donor transplants. HNA-3a antibodies were indicated following a retrospective flow cytometry crossmatch. Both patients received Basiliximab induction and both have experienced ABMR requiring supplementary immunosuppression., Conclusions: The predicted rate of HNA-3a antibodies amongst patients awaiting kidney transplant in the UK is <1%. However, with increasing evidence to support a role for HNA-3a antibodies in the development of ABMR there may be value in screening at risk groups to allow for augmented immunosuppression to be considered at the time of kidney transplant., Competing Interests: Declaration of Competing Interest None of the authors involved in the preparation of this manuscript have any conflicts of interest to declare., (Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF